fifty-four patients treated with daunorubicin , cytosine arabinoside and thioquanine for acute myeloid leukemia were randomly assigned to receive oral lithium carbonate 1200 mg daily or no lithium .
C0011015
daunorubicin
C0023467
acute myeloid leukemia